Its lower Gl leads to a slower, steadier increase in blood sugar, supporting better metabolic control
However, frequent stop-start cycles often lead to frustration and weight cycling, which is why most doctors recommend either continuous therapy or extended pauses with strong behavioral support
Archives of Neurology, 37(12), 749753
Endothelial LRP1 - A potential target for the treatment of Alzheimers disease : Theme: Drug discovery, development and delivery in Alzheimers disease guest editor: Davide Brambilla
With adequate lifestyle changes, the patient can eventually reduce the dosage or cease the medication altogether and see long-term weight loss
Initially developed as type 2 diabetes drugs, the emergence of GLP-1 receptor agonists (GLP-1 RAs) as effective weight loss agents has transformed the obesity therapeutic landscape, sparking a new wave of investment and innovation in obesity management with approaches that not only promote weight loss but also provide sustained metabolic and cardiovascular benefits
